Analysis of variants in DNA damage signalling genes in bladder cancer

Ananya Choudhury1, Faye Elliott, Mark M Iles

  • 1Cancer Research UK Clinical Centre, Section of Oncology, Leeds Institute of Molecular Medicine, Leeds, LS9 7TF, UK. ananya@doctors.org.uk

BMC Medical Genetics
|July 22, 2008
PubMed
Abstract

Insights

Single nucleotide polymorphisms (SNPs) in DNA double-strand break (DSB) signaling genes do not appear to significantly increase bladder cancer risk. This study found no strong evidence linking these genetic variations to bladder cancer predisposition or environmental exposure effects.

Area of Science:

  • Genetics and Cancer Epidemiology
  • Molecular Biology and DNA Repair Mechanisms
  • Environmental Health and Occupational Exposures

Background:

  • Occupational chemical exposure and cigarette smoke components can induce DNA damage in bladder urothelium.
  • Defective DNA repair can lead to mutations, genetic instability, and bladder cancer development.
  • DNA damage signaling acts as a tumor suppressor in early bladder lesions, but this function is lost during cancer progression.

Purpose of the Study:

  • To investigate the hypothesis that single nucleotide polymorphisms (SNPs) in DNA double-strand break (DSB) signaling genes influence bladder cancer predisposition.
  • To determine if these genetic variations modulate the impact of environmental exposures, such as smoking and occupational dye exposure, on bladder cancer risk.

Main Methods:

  • A case-control study involving 771 bladder cancer cases and 800 controls.
  • Genotyping of 24 SNPs in key DSB signaling genes (MRE11, NBS1, RAD50, H2AX, ATM) using Taqman allelic discrimination.
  • Interviews collected data on smoking habits and occupational history; logistic regression adjusted for confounders.

Main Results:

  • Smoking and occupational dye exposure were significantly associated with increased bladder cancer risk.
  • A marginal association was observed for one MRE11 3'UTR SNP (rs2155209) with bladder cancer risk in individuals homozygous for the rare allele.
  • No other tested SNPs showed a significant association with bladder cancer, nor did any SNPs interact with smoking or dye exposure.

Conclusions:

  • The study provides limited support for the hypothesis that SNPs in DSB signaling genes influence bladder cancer predisposition.
  • Apart from a potential marginal effect of one MRE11 SNP, the investigated genetic variations do not appear to be major modulators of bladder cancer risk.